Erudio Healtherudio.com
Clinical trial · no report yet · Early phase 1
NCT06691685
A Clinical Study to Evaluate the Safety and Efficacy of ESO-T01 in Treating Relapsed/Refractory Multiple Myeloma.
- NCT06691685 ↗
- Suspended
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Focused
We haven't built an HCP commentary report on NCT06691685 (ESO-T01 in Multiple Myeloma) yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Indexed commentary on NCT06691685 so far
Podcasts, YouTube videos and X posts we have indexed that name the trial. It is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.
| Channel | Indexed | |
|---|---|---|
| X threads | 3 |
The trial
ClinicalTrials.gov- Official title
- A Clinical Study to Evaluate the Safety and Efficacy of ESO-T01 in Treating Relapsed/Refractory Multiple Myeloma.
- Phase
- Early phase 1
- Status
- Suspended
- Conditions
- Multiple Myeloma
- Interventions
- ESO-T01 Injection
- Arms
- ESO-T01 Injection · Experimental
- Enrollment
- 24 (estimated)
- Primary outcomes
- Cytokine release syndrome (CRS)
- Dose-limiting toxicities (DLTs)
- immune cell-associated immune effector cell-associated neurotoxicity syndrome (ICANS)
- Treatment-associated adverse effects (AEs)
- Sponsor
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology with Shenzhen Pregene Biopharma Co., Ltd.
- Start
- Nov 18, 2024
- Primary completion
- Nov 1, 2027 (estimated)
- Results posted
- No
- Registry record
- NCT06691685 · updated Jul 22, 2026
Publications
linked from the registry- Xu J, Liu L, Xie W, Su L, Wang W, Li C, Liu Q, Kang Y, Zhang Y, Luo W, Huang Z, Zhang C, Sun C, Hu Y, Mei H. Extended follow-up of in vivo BCMA CAR-T therapy in relapsed/refractory multiple myeloma. Nat Med. 2026 Oct 6. doi: 10.1038/s41591-026-04704-z. Online ahead of print. PubMed 42839103